Taysha Gene Therapies TSHA
NASDAQ TSHA
$4.63 -0.11 (-2.32%)
At close: Oct 2, 2026 · 4:00 PM EDT

Taysha Gene Therapies (TSHA) Invested Capital (2021 - 2026)

Updated

Taysha Gene Therapies (TSHA) posted Invested Capital of $436.53 million for Q2 2026, up 50.6% from $289.78 million a year earlier and up 67.3% from the prior quarter.

Analysis

Taysha Gene Therapies (TSHA) Invested Capital (2021 - 2026) Analysis & Trends

For FY2025, Taysha Gene Therapies' Invested Capital came in at $297.04 million, up 157.3% from FY2024.

  • Annual Invested Capital shows a four-year compound annual growth rate of 22.3% (FY2021 to FY2025).
  • In prior years, Taysha Gene Therapies' Invested Capital was $115.47 million in FY2024 (unchanged), $115.45 million in FY2023 (+196.7%), $38.92 million in FY2022 (-70.6%) and $132.58 million in FY2021.
  • The Q2 2026 figure stands as the highest quarterly Invested Capital in data going back to Q3 2021.
  • On a year-over-year basis, Invested Capital has increased in each of the last six quarters, with growth averaging 83.0% over the last seven quarters.
  • The strongest year-over-year quarter for Invested Capital in the past five years was Q1 2024, with growth of 306.5%; the weakest was Q2 2023, with a decline of 98.2%.
  • According to Business Quant data, Invested Capital for the three prior quarters was $260.91 million (Q1 2026), $297.04 million (Q4 2025) and $269.84 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 88.79 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 134.01 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 64.89 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 95.89 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 79.44 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 50.26 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 68.99 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 38.08 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 148.69 Bn
10 Taysha Gene Therapies 1.54 Bn 1.54 Bn - 436.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 436.53 Mn
Mar 31, 2026 260.91 Mn
Dec 31, 2025 297.04 Mn
Sep 30, 2025 269.84 Mn
Jun 30, 2025 289.78 Mn
Mar 31, 2025 97.51 Mn
Dec 31, 2024 115.47 Mn
Sep 30, 2024 131.77 Mn
Jun 30, 2024 146.70 Mn
Mar 31, 2024 94.36 Mn
Dec 31, 2023 115.45 Mn
Sep 30, 2023 -10.57 Mn
Jun 30, 2023 1.24 Mn
Mar 31, 2023 23.21 Mn
Dec 31, 2022 38.92 Mn
Sep 30, 2022 48.48 Mn
Jun 30, 2022 70.09 Mn
Mar 31, 2022 88.13 Mn
Dec 31, 2021 132.58 Mn
Sep 30, 2021 168.21 Mn
API Access

Taysha Gene Therapies Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=TSHA&period=max&api_key=YOUR_API_KEY